Masimo Corporation (NASDAQ:MASI – Get Free Report) shares hit a new 52-week high on Friday . The company traded as high as $179.00 and last traded at $178.9450, with a volume of 220634 shares changing hands. The stock had previously closed at $178.90.
Analyst Ratings Changes
A number of brokerages have recently weighed in on MASI. BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a report on Tuesday, February 17th. Piper Sandler lowered shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective on the stock. in a report on Tuesday, February 17th. Finally, Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Nine research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Masimo presently has an average rating of “Hold” and a consensus target price of $180.40.
Read Our Latest Research Report on Masimo
Masimo Trading Down 0.0%
Institutional Trading of Masimo
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MASI. Global Retirement Partners LLC acquired a new stake in Masimo during the fourth quarter worth approximately $27,000. Aster Capital Management DIFC Ltd acquired a new stake in Masimo during the fourth quarter worth approximately $28,000. Los Angeles Capital Management LLC acquired a new stake in Masimo during the fourth quarter worth approximately $31,000. Rothschild Investment LLC increased its holdings in shares of Masimo by 12,950.0% in the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 259 shares during the period. Finally, Torren Management LLC purchased a new stake in Masimo in the 4th quarter valued at $35,000. Institutional investors and hedge funds own 85.96% of the company’s stock.
About Masimo
Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.
In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.
Recommended Stories
- Five stocks we like better than Masimo
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.
